What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.31%Above 5Y avg (0.98%)
Annual Rate
JPY 29.50Paid annual
Payout Ratio
41.6%Sustainable
Payback Period
0.3 yr
Next Ex-Dividend
Mar 30, 2027
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
112.70BJPY
706.10M · vs all stocks (USD)
Updated Aug 19, 2026
Revenue (TTM)
66.28BJPY
415.25M · vs all stocks (USD)
Updated Aug 19, 2026
Profit Margin
-21.92%
vs Health Information Services peers
Updated Aug 19, 2026
Beta
1.30x
vs all stocks
Updated Aug 19, 2026
52-Week Change
39.73%
vs all stocks
Updated Aug 19, 2026
Market Capitalization
112.70BJPY
706.10M · vs all stocks (USD)
Updated Aug 19, 2026
Enterprise Value
177.97BJPY
1.12B · vs all stocks (USD)
Updated Aug 19, 2026
Forward P/E
21.27x
vs Health Information Services peers
Updated Aug 19, 2026
Price to Sales (TTM)
2.83x
vs Health Information Services peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 1.7×.Updated Aug 19, 2026
Price to Book (MRQ)
6.64x
vs Health Information Services peers
Updated Aug 19, 2026
Enterprise to Revenue
2.69x
vs Health Information Services peers
Updated Aug 19, 2026
Enterprise to EBITDA
14.47x
vs Health Information Services peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 13.28×.Updated Aug 19, 2026
Profit Margin
-21.92%
vs Health Information Services peers
Updated Aug 19, 2026
Operating Margin
21.32%
vs Health Information Services peers
Updated Aug 19, 2026
Return on Assets (TTM)
7.38%
vs Health Information Services peers
Updated Aug 19, 2026
Return on Equity (TTM)
-40.27%
vs Health Information Services peers
Updated Aug 19, 2026
Revenue (TTM)
66.28BJPY
415.25M · vs all stocks (USD)
Updated Aug 19, 2026
Revenue per Share (TTM)
807.42JPYUpdated Aug 19, 2026
Quarterly Revenue Growth
8.20%
vs Health Information Services peers
Updated Aug 19, 2026
Gross Profit (TTM)
58.60BJPY
367.16M · vs all stocks (USD)
Updated Aug 19, 2026
EBITDA (TTM)
13.41BJPY
84.00M · vs all stocks (USD)
Updated Aug 19, 2026
Net Income (TTM)
-14.53BJPY
-91.03M · vs all stocks (USD)
Updated Aug 19, 2026
Quarterly Earnings Growth (YoY)
-5.40%
vs Health Information Services peers
Updated Aug 19, 2026
Operating Cash Flow (TTM)
8.80BJPY
55.13M · vs all stocks (USD)
Updated Aug 19, 2026
Levered Free Cash Flow (TTM)
-14.32BJPY
-89.70M · vs all stocks (USD)
Updated Aug 19, 2026
Trailing Annual Dividend Rate
29.50JPYUpdated Aug 19, 2026
Trailing Annual Dividend Yield
1.31%
vs all stocks
Updated Aug 19, 2026
5-Year Average Dividend Yield
0.98%
vs all stocks
Updated Aug 19, 2026
Payout Ratio
41.58%
vs Health Information Services peers
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives -16.99%.Updated Aug 19, 2026
Revenue
64.73BJPYFY2026 · Mar 31, 2026
Cost of Goods Sold
7.60BJPYFY2026 · Mar 31, 2026
Gross Profit
57.13BJPYFY2026 · Mar 31, 2026
Operating Income
6.79BJPY
42.52M · vs all stocks (USD)
FY2026 · Mar 31, 2026
Pre-tax Income
-14.43BJPYFY2026 · Mar 31, 2026
Income Tax Expense
-115.00MJPYFY2026 · Mar 31, 2026
Net Income
-14.32BJPYFY2026 · Mar 31, 2026
EBIT
-14.30BJPYFY2026 · Mar 31, 2026
EBITDA (Income Statement)
13.41BJPYFY2026 · Mar 31, 2026
Non-operating Interest Income
67.00MJPYFY2026 · Mar 31, 2026
Non-operating Interest Expense
130.00MJPYFY2026 · Mar 31, 2026
EPS (Basic)
-173.66JPYFY2026 · Mar 31, 2026
EPS (Diluted)
-173.66JPYFY2026 · Mar 31, 2026
Basic Shares Outstanding
82.45MSharesFY2026 · Mar 31, 2026
Diluted Shares Outstanding
82.45MSharesFY2026 · Mar 31, 2026
Minority Interests (P&L)
0.00JPYFY2026 · Mar 31, 2026
Preferred Stock Dividends
0.00JPYFY2026 · Mar 31, 2026
Operating Cash Flow
-16.58BJPYFY2026 · Mar 31, 2026
Free Cash Flow
-16.73BJPYFY2026 · Mar 31, 2026
Cash & Cash Equivalents (End of Period)
12.55BJPYFY2026 · Mar 31, 2026
Starting Profit (CF Statement)
-14.43BJPYFY2026 · Mar 31, 2026
Stock-based Compensation
-6.00MJPYFY2026 · Mar 31, 2026
Other Non-cash Items
180.00MJPYFY2026 · Mar 31, 2026
Change in Accounts Receivable (CF)
-2.42BJPYFY2026 · Mar 31, 2026
Change in Other Assets/Liabilities
97.00MJPYFY2026 · Mar 31, 2026
Capital Expenditures
-145.00MJPYFY2026 · Mar 31, 2026
Net Intangibles (CF)
-3.76BJPYFY2026 · Mar 31, 2026
Purchase of Investments
-224.00MJPYFY2026 · Mar 31, 2026
Other Investing Activity
4.00MJPYFY2026 · Mar 31, 2026
Net Investing Cash Flow
-365.00MJPYFY2026 · Mar 31, 2026
Long-term Debt Payments
-1.90BJPYFY2026 · Mar 31, 2026
Net Short-term Debt Issuance
1.10BJPYFY2026 · Mar 31, 2026
Common Stock Repurchase
-4.00BJPYFY2026 · Mar 31, 2026
Common Dividends Paid
-2.42BJPYFY2026 · Mar 31, 2026
Other Financing Charges
6.00MJPYFY2026 · Mar 31, 2026
Net Financing Cash Flow
-7.21BJPYFY2026 · Mar 31, 2026
Shares Outstanding
82.08MSharesUpdated Aug 19, 2026
Float Shares
30.35MSharesUpdated Aug 19, 2026
% Held by Insiders
21.57%
vs all stocks
Updated Aug 19, 2026
% Held by Institutions
58.05%
vs all stocks
Updated Aug 19, 2026
Total Cash (MRQ)
15.35BJPY
96.15M · vs all stocks (USD)
Updated Aug 19, 2026
Total Cash per Share (MRQ)
186.93JPYUpdated Aug 19, 2026
Total Debt (MRQ)
5.65BJPY
35.38M · vs all stocks (USD)
Updated Aug 19, 2026
Total Debt to Equity (MRQ)
0.1999x
vs Health Information Services peers
Updated Aug 19, 2026
Current Ratio (MRQ)
1.65x
vs Health Information Services peers
Updated Aug 19, 2026
Book Value per Share (MRQ)
344.18JPYUpdated Aug 19, 2026
Total Assets
52.77BJPY
330.64M · vs all stocks (USD)
FY2026 · Mar 31, 2026
Total Current Assets
38.41BJPYFY2026 · Mar 31, 2026
Total Liabilities
26.05BJPYFY2026 · Mar 31, 2026
Total Non-current Assets
14.36BJPYFY2026 · Mar 31, 2026
Total Non-current Liabilities
1.47BJPYFY2026 · Mar 31, 2026
Total Current Liabilities
24.58BJPYFY2026 · Mar 31, 2026
Cash & Cash Equivalents
13.73BJPYFY2026 · Mar 31, 2026
Accounts Receivable
9.56BJPYFY2026 · Mar 31, 2026
Inventory
72.00MJPYFY2026 · Mar 31, 2026
Accounts Payable
405.00MJPYFY2026 · Mar 31, 2026
Short-term Debt
6.02BJPYFY2026 · Mar 31, 2026
Other Current Liabilities
673.00MJPYFY2026 · Mar 31, 2026
Long-term Debt
1.22BJPYFY2026 · Mar 31, 2026
Other Non-current Liabilities
5.00MJPYFY2026 · Mar 31, 2026
Common Stock (Book)
2.55BJPYFY2026 · Mar 31, 2026
Retained Earnings
26.69BJPYFY2026 · Mar 31, 2026
Total Shareholders' Equity
26.72BJPY
167.43M · vs all stocks (USD)
FY2026 · Mar 31, 2026
Treasury Stock
9.71BJPYFY2026 · Mar 31, 2026
52-Week Low
1.26KJPYUpdated Aug 19, 2026
52-Week High
2.62KJPYUpdated Aug 19, 2026
52-Week Change
39.73%
vs all stocks
Updated Aug 19, 2026
Beta
1.30x
vs all stocks
Updated Aug 19, 2026
50-Day MA
2.23KJPYUpdated Aug 19, 2026
200-Day MA
1.76KJPYUpdated Aug 19, 2026
Avg 10-Day Volume
481.30KSharesUpdated Aug 19, 2026
Avg 30-Day Volume
571.45KSharesUpdated Aug 19, 2026
Diluted EPS (TTM)
-173.65JPYUpdated Aug 19, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
What customers owe has grown three years running, while it clears stock quickly and pays suppliers quickly.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.